Jabil Director Sells 1,000 Shares, Collects $246,000 in Two Trades

JBLJBL

Jabil director Anousheh Ansari sold 500 shares at an average of $240 on Jan 13 and another 500 shares at $252 on Jan 15, netting $246,000 in insider sales. These transactions cut her stake by 1.43% then 1.45%, leaving her with 33,900 shares valued at $8.54 million.

1. Director’s Recent Share Disposals Signal Caution

Jabil Director Anousheh Ansari executed three separate share sales between mid-December and mid-January, disposing of 2,500 shares in total. The latest sale on January 13th involved 500 shares for proceeds of $120,000, reducing her stake by 1.43% to 34,400 shares. Shortly thereafter on January 15th she sold another 500 shares for $126,000, and in December offloaded 1,500 shares for $337,500. These sales were disclosed via SEC filings and mark a concentrated cluster of insider liquidations over a two-month span, a pattern investors often interpret as a signal to reassess near-term expectations for the business.

2. Q4 Earnings Beat and FY2026 Guidance Point to Continued Momentum

On December 17th, Jabil reported fourth-quarter revenue of $8.31 billion, outpacing consensus estimates by $240 million, and delivered adjusted earnings per share of $2.85, topping forecasts by $0.15. Year-over-year revenue rose 18.7%, while net margin held at 2.26% and return on equity reached 75.96%. The company set full-year 2026 EPS guidance at 11.55 and projected Q2 EPS between 2.27 and 2.67. Management highlighted expansion in high-margin services and automotive electronics as primary drivers. Analysts’ average estimate for fiscal 2026 stands at 8.05 EPS, reflecting mixed views on margin sustainability versus top-line growth.

3. Institutional Positioning and Analyst Ratings Reflect Bullish Tilt

Institutional ownership remains high at 93.4%, with major additions by Norges Bank, Arrowstreet Capital and Boston Partners, each accumulating stakes valued in the hundreds of millions. On the sell-side, JPMorgan and Goldman Sachs have recently raised their price targets and maintained overweight or buy ratings, while UBS and Weiss Ratings hold neutral or hold views. Of ten covered firms, eight rate the stock at buy or stronger, supporting a consensus target above current trading multiples. Investors will monitor how fresh capital from large institutions and ongoing corporate guidance align with valuation measures such as a PEG ratio near 1.6.

Sources

DD